EDX Medical Group plc (AQSE: EDX): Commercial launch of comprehensive bowel cancer testing service (BC95)Eden Research plc (AIM: EDEN): Appointment of Syngenta as distribution partnerAvacta Therapeutics plc (AIM: AVCT): New pharmacology data for AVA6103
18 Dec 2025
SP Angel Healthcare Conditions
Sign up to access
Get access to our full offering from over 100 providers
Get access to our full offering from over 100 providers
SP Angel Healthcare Conditions
Avacta Group PLC (AVCT:LON), 54.5 | Eden Research plc (EDEN:LON), 3.6
- Published:
18 Dec 2025 -
Author:
Vadim Alexandre | Greg Pave -
Pages:
4 -
EDX Medical Group plc (AQSE: EDX): Commercial launch of comprehensive bowel cancer testing service (BC95)Eden Research plc (AIM: EDEN): Appointment of Syngenta as distribution partnerAvacta Therapeutics plc (AIM: AVCT): New pharmacology data for AVA6103